These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19172900)

  • 21. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    Ghorbani A; Abundo MC; Ji H; Taylor KJM; Ngunjiri JM; Lee CW
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confronting the avian influenza threat: vaccine development for a potential pandemic.
    Stephenson I; Nicholson KG; Wood JM; Zambon MC; Katz JM
    Lancet Infect Dis; 2004 Aug; 4(8):499-509. PubMed ID: 15288823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live recombinant Salmonella oral vaccine against avian influenza viruses.
    Huang JD; Zheng BJ; Yuen KY
    Hong Kong Med J; 2015 Jun; 21 Suppl 4():14-6. PubMed ID: 26157096
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccines and veterinarians to tackle the spread of avian influenza.
    J Am Vet Med Assoc; 2006 Apr; 228(7):999-1000. PubMed ID: 16596749
    [No Abstract]   [Full Text] [Related]  

  • 28. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccines.
    Ellebedy AH; Webby RJ
    Vaccine; 2009 Nov; 27 Suppl 4(Suppl 4):D65-8. PubMed ID: 19837290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avian influenza vaccines and therapies for poultry.
    Swayne DE
    Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):351-63. PubMed ID: 18442853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ligands for Toll-like receptors 3, 4, and 21 as adjuvants on the immunogenicity of an avian influenza vaccine in chickens.
    St Paul M; Barjesteh N; Brisbin JT; Villaneueva AI; Read LR; Hodgins D; Nagy É; Sharif S
    Viral Immunol; 2014 May; 27(4):167-73. PubMed ID: 24797893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines against influenza A viruses in poultry and swine: Status and future developments.
    Rahn J; Hoffmann D; Harder TC; Beer M
    Vaccine; 2015 May; 33(21):2414-24. PubMed ID: 25835575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Dr von Magnus to blame for the withdrawal of live attenuated influenza vaccine?
    Griffiths PD
    Rev Med Virol; 2018 Jan; 28(1):. PubMed ID: 29143392
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccines in development against avian influenza.
    Cox MM
    Minerva Med; 2007 Apr; 98(2):145-53. PubMed ID: 17519856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Employing XIAP to enhance the duration of antigen expression and immunity against an avian influenza H5 DNA vaccine.
    Tabatabaeizadeh SE; Bassami MR; Haghparast A; Dehghani H
    Immunol Invest; 2015; 44(3):199-215. PubMed ID: 25831080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
    Song H; Nieto GR; Perez DR
    J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Live cold-adapted influenza vaccine: state-of-the-art].
    Gendon IuZ
    Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant viruses of poultry as vector vaccines against fowl plague].
    Fuchs W; Veits J; Mettenleiter TC
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):160-6. PubMed ID: 16573206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel method to produce Influenza A virus matrix protein M1 Capsid Like Particles (CLPs).
    Baniasadi V; Lal SK
    J Virol Methods; 2014 Sep; 205():1-2. PubMed ID: 24797458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Construction and immunogenicity of attenuated Salmonella typhimurium harbouring stable DNA vaccine against H5 subtype of avian influenza virus].
    Tang LH; Pan ZM; Cheng NN; Jiao XA; Zhang XM
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):662-6. PubMed ID: 17944368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.